Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure. (Q51373277)

4 April 2018

title

Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure. (English)

1 reference

4 April 2018

0 references

1 reference

5

1 reference

4 April 2018

author name string

Meimei Yin

1

1 reference

4 April 2018

Iwan C C van der Horst

2

1 reference

4 April 2018

Joost P van Melle

3

1 reference

4 April 2018

Cheng Qian

4

1 reference

4 April 2018

Herman H W Silljé

6

1 reference

4 April 2018

Rudolf A de Boer

7

1 reference

4 April 2018

publication date

13 May 2011

1 reference

4 April 2018

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

4 April 2018

volume

301

1 reference

4 April 2018

page(s)

H459-68

1 reference

4 April 2018

issue

2

1 reference

4 April 2018

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with hear

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Increased expression of cardiac angiotensin II type 1 (AT(1)) receptors decreases myocardial microvessel density after experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Identification of potential caloric restriction mimetics by microarray profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Sensing of energy and nutrients by AMP-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Effects of KATP channel modulation on myocardial glycogen content, lactate, and amino acids in nonischemic and ischemic rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

AMP-activated protein kinase and muscle glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Diabetes, glycemic control, and new-onset heart failure in patients with stable coronary artery disease: data from the heart and soul study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00054.2011

10.1152/AJPHEART.00054.2011

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

21572014

1 reference

4 April 2018